Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304
- Citation:
- J Thorac Oncol vol 6 (11) 1902-1906
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 686
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, CA77597, CA11789, CA77406, CA47577, CA29165, CA41287, U10 CA031946, U10 CA033601, CA59518, CA60138, CA45389, CA37447, CA45808, CA12046, CA35421, CA16450, CA77440, CA08025, CA21060, CA47559, CA47642, CA45418, CA31983, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Martin J. Edelman Lydia Hodgson Xiaofei Wang Robert Christenson Scott Jewell Everett Vokes Robert Kratzke
- Networks:
- Study
- CALGB-150304
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-30203
- Phases:
- N/A, 2
- Keywords:
- Lung cancer, VEGF, Eicosanoid, Celecoxib